Catherine Lynch - BlackRock Science Independent Trustee
BST Etf | USD 36.96 0.43 1.18% |
Age | 60 |
Tenure | 8 years |
Phone | 212 810 5300 |
Web | https://www.blackrock.com/investing/products/270141/blackrock-science-and-technology-trust-fund |
Catherine Lynch Latest Insider Activity
Tracking and analyzing the buying and selling activities of Catherine Lynch against BlackRock Science etf is an integral part of due diligence when investing in BlackRock Science. Catherine Lynch insider activity provides valuable insight into whether BlackRock Science is net buyers or sellers over its current business cycle. Note, BlackRock Science insiders must abide by specific rules, including filing SEC forms every time they buy or sell BlackRock Science'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Catherine Lynch over a month ago Insider Trading | ||
Catherine Lynch over a month ago Acquisition by Catherine Lynch of 128 shares of BlackRock Credit subject to Rule 16b-3 | ||
Catherine Lynch over two months ago Acquisition by Catherine Lynch of 184 shares of BlackRock Credit subject to Rule 16b-3 | ||
Catherine Lynch over three months ago Acquisition by Catherine Lynch of tradable shares of BlackRock Health subject to Rule 16b-3 |
Similar Fund Executives
Showing other executives | One Year Return | ||
Frank Fabozzi | Blackrock Innovation Growth | 73 | |
Jay Fife | Blackrock Innovation Growth | 51 | |
J Holloman | BlackRock Health Sciences | 66 | |
Marcus Smith | Eaton Vance Enhanced | 54 | |
Xiang Liu | BlackRock Health Sciences | N/A | |
Robin Batchelor | BlackRock Utility Infrastructur | N/A | |
W Kester | BlackRock Health Sciences | 70 | |
Richard Froio | Eaton Vance Enhanced | 53 | |
Jonathan Diorio | BlackRock Health Sciences | 41 | |
Deidre Walsh | Eaton Vance Enhanced | 50 | |
Robert Fairbairn | Blackrock Innovation Growth | 56 | |
Antonio III | BlackRock Utility Infrastructur | 56 | |
Christopher Accettella | BlackRock Utility Infrastructur | N/A | |
Kathleen Anderson | BlackRock Utility Infrastructur | N/A | |
Janey Ahn | Blackrock Innovation Growth | 46 | |
George Batejan | Columbia Seligman Premium | 67 | |
Alastair Bishop | BlackRock Utility Infrastructur | N/A | |
Cynthia Egan | BlackRock Health Sciences | 66 | |
Jeffrey Lee | BlackRock Health Sciences | N/A | |
Richard Cavanagh | Blackrock Innovation Growth | 75 | |
R Hubbard | Blackrock Innovation Growth | 63 |
BlackRock Science Tech Money Managers
Henry Gabbay, Independent Trustee | ||
Karen Robards, Independent Co-Chairman of the Board of Trustees | ||
Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
Charles Park, Chief Compliance Officer, Anti-Money Laundering Officer | ||
Frank Fabozzi, Independent Trustee | ||
J Holloman, Independent Trustee | ||
Janey Ahn, Secretary | ||
John Perlowski, President, Chief Executive Officer, Trustee | ||
Michael Castellano, Independent Trustee | ||
Cynthia Egan, Independent Trustee | ||
Jay Fife, Treasurer | ||
R Hubbard, Independent Trustee | ||
Jonathan Diorio, Vice President | ||
Robert Fairbairn, Trustee | ||
Neal Andrews, Chief Financial Officer | ||
Trent Walker, Chief Financial Officer | ||
Catherine Lynch, Independent Trustee | ||
Stayce Harris, Independent Trustee | ||
W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Shares Outstanding | 33.68 M | ||||
Shares Owned By Insiders | 0.01 % | ||||
Shares Owned By Institutions | 18.53 % | ||||
Number Of Shares Shorted | 14.74 K | ||||
Price To Earning | 5.78 X | ||||
Short Ratio | 0.09 X | ||||
Earnings Per Share | 5.41 X | ||||
Number Of Employees | 17 | ||||
Market Capitalization | 1 B | ||||
Total Asset | 22.91 M |
Pair Trading with BlackRock Science
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BlackRock Science position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BlackRock Science will appreciate offsetting losses from the drop in the long position's value.Moving together with BlackRock Etf
0.66 | BRAPX | Blackrock Aggressive | PairCorr |
0.79 | BRCPX | Blackrock Conservative | PairCorr |
0.85 | BRGPX | Blackrock Gwth Prepared | PairCorr |
0.72 | BRICX | Blackrock Retirement | PairCorr |
0.89 | BRMPX | Blackrock Moderate | PairCorr |
The ability to find closely correlated positions to BlackRock Science could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BlackRock Science when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BlackRock Science - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BlackRock Science Tech to buy it.
The correlation of BlackRock Science is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BlackRock Science moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BlackRock Science Tech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BlackRock Science can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BlackRock Science Tech. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
The market value of BlackRock Science Tech is measured differently than its book value, which is the value of BlackRock that is recorded on the company's balance sheet. Investors also form their own opinion of BlackRock Science's value that differs from its market value or its book value, called intrinsic value, which is BlackRock Science's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BlackRock Science's market value can be influenced by many factors that don't directly affect BlackRock Science's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BlackRock Science's value and its price as these two are different measures arrived at by different means. Investors typically determine if BlackRock Science is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BlackRock Science's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.